InMed Pharmaceuticals (INM) Exchange Rate Effect (2019 - 2020)

InMed Pharmaceuticals (INM) reported Exchange Rate Effect of $367235.0 for Q4 2020, up 62.07% on a YoY basis from $226587.0 in Q1 2020, and up 187.52% quarter-over-quarter from $127725.0 in Q3 2020.

InMed Pharmaceuticals (INM) Exchange Rate Effect (2019 - 2020) Analysis & Trends

InMed Pharmaceuticals has reported Exchange Rate Effect for 2 years, with the latest figure at $367235.0 in Q4 2020.

  • For the quarter ending Q4 2020, Exchange Rate Effect rose 62.07% year-over-year to $367235.0; the trailing twelve-month figure through Jun 2021 stood at $494960.0 (up 218.88% YoY), and the FY2021 full-year result was $494960.0, up 218.88% from the prior year.
  • Exchange Rate Effect for Q4 2020 stood at $367235.0, up from $127725.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $367235.0 in Q4 2020, with the low at -$700247.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FX Effect (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -17.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 17.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -5.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -22,000.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -2.38 Mn
10 InMed Pharmaceuticals 6.00 Mn 756,271.05 - -

Historic Data

Download Data
DateValue
Dec 31, 2020 367,235.00
Dec 31, 2020 367,235.00
Sep 30, 2020 127,725.00
Sep 30, 2020 127,725.00
Jun 30, 2020 265,857.00
Jun 30, 2020 265,857.00
Mar 31, 2020 -700,247.00
Mar 31, 2020 -700,247.00
Dec 31, 2019 226,587.00
Dec 31, 2019 226,587.00
Sep 30, 2019 -208,550.00
Sep 30, 2019 -208,550.00